Seeking Alpha

J&J's (JNJ -0.5%) Janssen Pharmaceuticals settles with 36 states and the District of...

J&J's (JNJ -0.5%) Janssen Pharmaceuticals settles with 36 states and the District of Columbia regarding allegations related to promotional and marketing practices for its anti-psychotic medication Risperdal. Under the terms of the agreement, the company will pay approximately $181M, with predesignated portions to be paid to each state participating in the settlement.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector